| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0168-8278(92)90186-S |
| P8608 | Fatcat ID | release_x3g4krenf5eldewi5zhdl6meii |
| P698 | PubMed publication ID | 1380026 |
| P50 | author | Alastair Burt | Q41875029 |
| P2093 | author name string | Bennett MK | |
| Bassendine MF | |||
| May FE | |||
| Corbett IP | |||
| Guo K | |||
| Mathew J | |||
| Collier JD | |||
| P433 | issue | 2-3 | |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 377-380 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma | |
| P478 | volume | 14 |
| Q34978321 | Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. |
| Q34253944 | Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies |
| Q36622264 | Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma |
| Q38450888 | Expression of Kit and platelet-derived growth factor receptors α and β in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571) |
| Q38456543 | Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry |
| Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
| Q91728336 | HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis |
| Q39040859 | HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? |
| Q27478238 | Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis |
| Q30165307 | Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma |
| Q35764997 | NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia. |
| Q35588545 | Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma |
| Q37351498 | Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma |
| Q71663447 | Serum levels of c-erbB-2 protein in digestive diseases |
| Q58601441 | The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers |
| Q36395424 | The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma |
| Q41098848 | The molecular pathogenesis of hepatocellular carcinoma. |
Search more.